More Globe Newswire

View Older Stories View Newer Stories

Sep 3, 2024 04:15PM Microchip Technology to Present at the Citi 2024 Global TMT Conference
Sep 3, 2024 04:15PM AMD Appoints AI Industry Veteran Keith Strier to Expand Global AI Capabilities and Engagements
Sep 3, 2024 04:15PM Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
Sep 3, 2024 04:14PM Grocery Outlet Launches Private Label Program, GO Brands
Sep 3, 2024 04:05PM Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share
Sep 3, 2024 04:05PM Codexis to Participate in Upcoming Healthcare Conferences
Sep 3, 2024 04:05PM Wintrust Appoints New Head of Diversity, Equity, and Inclusion
Sep 3, 2024 04:05PM Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share
Sep 3, 2024 04:05PM Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
Sep 3, 2024 04:05PM INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement
Sep 3, 2024 04:05PM Zscaler Reports Fourth Quarter and Fiscal 2024 Financial Results
Sep 3, 2024 04:05PM Sportsman’s Warehouse Holdings, Inc. Announces Second Quarter 2024 Financial Results
Sep 3, 2024 04:05PM The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest
Sep 3, 2024 04:05PM Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024
Sep 3, 2024 04:05PM FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Sep 3, 2024 04:05PM X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 3, 2024 04:05PM Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference
Sep 3, 2024 04:05PM H&R Block to Participate in the Barclays Global Financial Services Conference
Sep 3, 2024 04:05PM Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Sep 3, 2024 04:05PM Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
Sep 3, 2024 04:05PM Rani Therapeutics to Participate in September Investor Conferences
Sep 3, 2024 04:05PM Elutia to Participate in Upcoming Investor Conferences
Sep 3, 2024 04:05PM Richtech Robotics Announces Closing of $21 Million Public Offering
Sep 3, 2024 04:05PM GitLab Reports Second Quarter Fiscal Year 2025 Financial Results
Sep 3, 2024 04:05PM Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Sep 3, 2024 04:05PM Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
Sep 3, 2024 04:05PM ParaZero Announces First Half of 2024 Financial Results
Sep 3, 2024 04:05PM Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Sep 3, 2024 04:05PM ACM Research Expands Fan-Out Panel-Level Packaging Portfolio with Launch of Ultra C bev-p Bevel Etching Tool
Sep 3, 2024 04:05PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Sep 3, 2024 04:01PM Monroe Capital Corporation Announces Third Quarter Distribution of $0.25 Per Share
Sep 3, 2024 04:01PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Sep 3, 2024 04:01PM Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
Sep 3, 2024 04:01PM Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
Sep 3, 2024 04:01PM Premium Global Income Split Corp. Declares Monthly Distribution
Sep 3, 2024 04:01PM HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results
Sep 3, 2024 04:01PM Nkarta to Participate in Upcoming Investor Conference
Sep 3, 2024 04:01PM Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease
Sep 3, 2024 04:01PM Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
Sep 3, 2024 04:01PM Galapagos receives transparency notification from FMR LLC
Sep 3, 2024 04:01PM Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly Distribution
Sep 3, 2024 04:00PM Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences
Sep 3, 2024 04:00PM Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference
Sep 3, 2024 03:58PM Royal Farms Expands in North Carolina with the Grand Opening of a New Store in Columbia
Sep 3, 2024 03:55PM Blue Biofuels Produces Ethanol in High Yield from Multiple Feedstocks in its Upscaled CTS Process
Sep 3, 2024 03:54PM Sun Communities, Inc. Declares Third Quarter 2024 Distribution
Sep 3, 2024 03:44PM Avid Artist Interviews Spotlight Emmy® Award-nominated Editors from the Avid User Community
Sep 3, 2024 03:42PM Mysten Labs Unveils Specs and Updates on SuiPlay0X1; The First Blockchain-Based Handheld Gaming Device
Sep 3, 2024 03:31PM Cherokee Federal’s Growth Capital Division Acquires Majority Stake in ATA, LLC
Sep 3, 2024 03:31PM Allocation of Restricted Share Units
View Newer Stories View Older Stories